Brokerages Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.00
Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price […]
Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price […]
